Aram Yegiazaryan

Statistics

Publications

Citations

100

H-Index

Active since

2020

Affiliations

Western University of Health Sciences(Current)

Aram Yegiazaryan is an author at Western University of Health Sciences specializing in mycobacterium tuberculosis infection, tuberculosis pharmacotherapy, and pharmacology.

ORCID

Publications per year

2020–2021

Publications

Antimycobacterial Effects of Everolimus in a Human Granuloma Model

David J. B. Ashley, Joshua Hernandez, Ruoqiong Cao et al. · Journal of Clinical Medicine · 2020 · 44 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes

Kimberly To, Ruoqiong Cao, Aram Yegiazaryan et al. · Frontiers in Cellular and Infection Microbiology · 2021 · 31 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +15

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against <i>Mycobacterium bovis</i> BCG Strain in Individuals with Type 2 Diabetes

Kimberly To, Ruoqiong Cao, Aram Yegiazaryan et al. · BioMolecular Concepts · 2021 · 13 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Cyclic Peptide [R4W4] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas

Joshua Hernandez, David J. B. Ashley, Ruoqiong Cao et al. · Frontiers in Immunology · 2020 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–4 of 4